Jamie Dwyer, MD
Enriched profileAssociate Dean for Clinical Research, University of Utah Health School of Medicine; Assistant Vice-President for Clinical Research; Professor of Medicine, Division of Nephrology and Hypertension · University of Utah Health
Jamie Dwyer is Associate Dean for Clinical Research, University of Utah Health School of Medicine; Assistant Vice-President for Clinical Research; Professor of Medicine, Division of Nephrology and Hypertension at University of Utah Health. OpenAlex indexes 162 publications with 8,711 citations (h-index 43); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Jamie P. Dwyer, MD, is Associate Dean for Clinical Research, University of Utah Health School of Medicine. The public record shows 162 publications with 8,711 citations (h-index 43), centered on Chronic Kidney Disease and Diabetes, Diabetes Treatment and Management, Blood Pressure and Hypertension Studies. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 20 companies.
- Most recent indexed publication: 2026 · Journal of the American Society of Nephrology
- Top research focus: Chronic Kidney Disease and Diabetes
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 20 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 77.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)
Sponsor: AstraZeneca
- Pyridorin in Diabetic Nephropathy
Sponsor: NephroGenex, Inc.
Industry payments
Updated 27 Aug 2026
20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202535 payments$68,103openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20256 payments$31,175openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year20251 payment$22,250openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.6%ACE inhibitor35.3%Lisinopril100%Part D<11 patientsCalcium channel blocker32.4%Amlodipine Besylate100%Part D<11 patientsMetabolism & gastrointestinal
32.4%Metabolic Alkalinizer32.4%Potassium Citrate Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 27 Aug 2026
4 congress contributions (2019–2022) across ADA per OpenAlex. The most recent:
- 864-P: Glycemic Control across eGFR Categories with the Dual SGLT1 and 2 Inhibitor Sotagliflozin in SCORED
ADA Scientific Sessions
ADA2022Co-authorPoster - 303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial
ADA Scientific Sessions
ADA2020Co-authorOral - 236-OR: Effects of Dapagliflozin on Progression of Diabetic Kidney Disease: Analysis from DECLARE-TIMI 58 Trial
ADA Scientific Sessions
ADA2019Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal of the American Society of Nephrology
Article2026 - Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial.
Journal of the American Society of Nephrology
Article2024 - Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT.
Clinical journal of the American Society of Nephrology
Clinical Trial2024 - Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study.
ClinicoEconomics and outcomes research
Article2023
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/cv/jamie-p-dwyer-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/jamiepdwyer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Jamie-P-Dwyer-15776276
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗
- Internal Medicine residency
Mayo Clinic Florida (served as Chief Medical Resident)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗ - Nephrology fellowship and Clinical Research training
Vanderbilt University Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗ - Board Certified
Internal Medicine and Nephrology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- Director
Utah Data Coordinating Center (DCC)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Director
Clinical Research Support Office, Clinical and Translational Science Institute, University of Utah
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗
Awards & honors
honors on the public record- 2025 Paul Dudley White International Scholar Award
American Heart Association, awarded for the highest-scoring abstract submitted from the United States to the AHA Hypertension Scientific Sessions 2025
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.utah.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗
Secondary affiliations
appointments beyond the home institution- Prior faculty appointment
Vanderbilt University Medical Center, Division of Nephrology (joined 2008, until 2022 move to Utah); Director/Co-Director, Vanderbilt Nephrology Clinical Trials Center
2022provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗ - Prior faculty appointment
Mayo Clinic Florida (Internal Medicine, Chief Medical Resident)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academic-med.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.